Catalent Stock Current Valuation
Valuation analysis of Catalent helps investors to measure Catalent's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Catalent Company Current Valuation Analysis
Catalent's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Catalent Current Valuation | 16.13 B |
Most of Catalent's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Catalent is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
CompetitionIn accordance with the recently published financial statements, Catalent has a Current Valuation of 16.13 B. This is 12.33% higher than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The current valuation for all United States stocks is 2.95% higher than that of the company.
Catalent Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Catalent's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Catalent could also be used in its relative valuation, which is a method of valuing Catalent by comparing valuation metrics of similar companies.Catalent is currently under evaluation in current valuation category among its peers.
Catalent Fundamentals
Return On Equity | -0.11 | |||
Return On Asset | -0.0018 | |||
Profit Margin | (0.09) % | |||
Operating Margin | (0.07) % | |||
Current Valuation | 16.13 B | |||
Shares Outstanding | 181.51 M | |||
Shares Owned By Insiders | 0.50 % | |||
Shares Owned By Institutions | 87.80 % | |||
Number Of Shares Shorted | 14.74 M | |||
Price To Earning | 17.80 X | |||
Price To Book | 3.25 X | |||
Price To Sales | 2.61 X | |||
Revenue | 4.38 B | |||
Gross Profit | 1.04 B | |||
EBITDA | (284 M) | |||
Net Income | (1.04 B) | |||
Cash And Equivalents | 345 M | |||
Cash Per Share | 1.92 X | |||
Total Debt | 4.92 B | |||
Debt To Equity | 0.90 % | |||
Current Ratio | 2.86 X | |||
Book Value Per Share | 19.52 X | |||
Cash Flow From Operations | 268 M | |||
Short Ratio | 7.89 X | |||
Earnings Per Share | (2.28) X | |||
Price To Earnings To Growth | 529.00 X | |||
Target Price | 63.4 | |||
Number Of Employees | 17 K | |||
Beta | 1.16 | |||
Market Capitalization | 11.52 B | |||
Total Asset | 9.75 B | |||
Retained Earnings | (781 M) | |||
Working Capital | 1.57 B | |||
Current Asset | 790.2 M | |||
Current Liabilities | 391.2 M | |||
Net Asset | 9.75 B |
Thematic Opportunities
Explore Investment Opportunities
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Other Consideration for investing in Catalent Stock
If you are still planning to invest in Catalent check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Catalent's history and understand the potential risks before investing.
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Stocks Directory Find actively traded stocks across global markets |